• 1
    Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997; 113: 198391.
  • 2
    Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter infection and the development of gastric cancer. N Engl J Med 2001; 345: 7849.
  • 3
    Hsu PI, Lai KH, Lo GH, et al. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients. Gut 2002; 51: 1520.
  • 4
    Go MF. Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16(Suppl. 1): 315.
  • 5
    Weel JF, Van Der Hulst RWM, Gerrits Y, et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related disease. J Infect Dis 1996; 173: 11715.
  • 6
    Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection of Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 21115.
  • 7
    Censini S, Stein M, Covacci A. Cellular responses induced after contact with Helicobacter pylori. Curr Opin Microbiol 2001; 4: 416.
  • 8
    Covacci A, Telford JL, Del Giudice G, et al. Helicobacter pylori virulence and genetic geography. Science 1999; 284: 132833.
  • 9
    Hsu PI, Hwang IR, Cittelly D, et al. Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol 2002; 97: 22318.
    Direct Link:
  • 10
    Kuipers EJ, Perez-Perez GI, Meuwissen SG, et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995; 87: 177780.
  • 11
    Van Doorn LJ, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998; 115: 5866.
  • 12
    Figueiredo C, Van Doorn LJ, Nogueira C, et al. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and reveal a high prevalence of infections with multiple strains. Scand J Gastroenterol 2001; 36: 12835.
  • 13
    Yamaoka Y, Souchek J, Odenbreit S, et al. Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol 2002; 40: 22446.
  • 14
    Yamaoka Y, Kodama T, Gutierrez O, et al. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999; 37: 22749.
  • 15
    El-Omar EM. Gastric cancer and H. pylori: host genetics open the way. Gastroenterology 2001; 21: 10024.
  • 16
    Go MF. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology 1997; 113: S1520.
  • 17
    El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398402.
  • 18
    Machado JC, Pharoah P, Sousa S, et al. Interleukin-1b and interleukin-1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121: 8239.
  • 19
    Yamaoka Y, Kita M, Kodama Y, et al. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996; 110: 174452.
  • 20
    Wallace JL, Cucala M, Mugridge K, et al. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991; 261: G55964.
  • 21
    Luomala M, Lehtimaki T, Elovaara I, et al. A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis. J Neurol Sci 2001; 185: 1237.
  • 22
    Endres S, Cannon JG, Ghorbani R, et al. In vitro production of IL-1 beta, IL-1 alpha, TNF and IL-2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 1989; 19: 232733.
  • 23
    Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 4034.
  • 24
    Danis VA, Millington M, Hyland VJ, et al. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 30310.
  • 25
    Santtila S, Savinainen K, Hurme M. Presence of IL-1RA allele 2 (IL-1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998; 47: 1958.
  • 26
    Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793803.
  • 27
    Lauren P. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma. An attempt at histoclinical classification. Acta Pathol Microbiol Scand 1965; 64: 3149.
  • 28
    Hsu PI, Lai KH, Tseng HH, et al. Risk factors for presentation with bleeding in patients with Helicobacter pylori-related peptic ulcer diseases. J Clin Gastroenterol 2000; 30: 38691.
  • 29
    Hsu PI, Lai KH, Tseng HH, et al. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment Pharmacol Ther 2001; 15: 195201.
  • 30
    Wilkinson RJ, Patel P, Llewelyn M, et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 1999; 189: 186374.
  • 31
    Mansfield JC, Holden H, Tarlow JK, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 3742.
  • 32
    Hsu PI, Lai KH, Tseng HH, et al. Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia. J Clin Gastroenterol 1997; 25: 58791.
  • 33
    Lo CH, Hsu PI, Lo GH, et al. Comparison of clinical, serological and histological findings between non-ulcer dyspepsia patients with and without Helicobacter pylori infection. J Gastroenterol Hepatol 2001; 16: 27681.
  • 34
    Dixon MF, Genta RM, Yardly JH, et al. Classification and grading of gastritis. The Updated Sydney System. Am J Surg Pathol 1996; 20: 116181.
  • 35
    Parkin DM, Pisani P, Ferlay J. Estimates of worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 82741.
  • 36
    The EuroGast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 135962.
  • 37
    Watanabe T, Tada M, Nagai H, et al. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998; 115: 6428.
  • 38
    Uemura N, Okamoto S. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer in Japan. Gastroenterol Clin North Am 2000; 29: 81927.
  • 39
    Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2: 2837.
  • 40
    McColl KM, El-Omar E. Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer. Scand J Gastroenterol Suppl 1996; 215: 327.
  • 41
    Beales IL, Calam J. Interleukin 1 beta and tumor necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998; 42: 22734.
  • 42
    Figueiredo C, Machado JC, Pharoah P, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94: 16807.
  • 43
    Kato S, Onda M, Yamada S, et al. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001; 36: 6969.